Biocept
Biocept Files for Chapter 7 Bankruptcy
The company had previously announced it was laying off 35 percent of its workforce, and the Chapter 7 filing follows a consideration for strategic alternatives.
In Brief This Week: DermTech, Cerca Biotech, Colossal Biosciences, Biocept, Abbott, More
News items for the week of Sept. 18, 2023
Biocept Licenses CNSide Liquid Biopsy Assay to Plus Therapeutics
Under the agreement, Plus is using the cerebrospinal fluid cell-based assay in its ongoing clinical trial of the radiotherapeutic rhenium 186 obisbemeda.
In Brief This Week: Illumina, Thermo Fisher, Tempus, Bionano Genomics, Danaher, More
News items for the week of Aug. 14, 2023
People in the News at Thermo Fisher, Oxford Nanopore, Biocept, Element Biosciences, More
Executive appointments, promotions, and departures in omics and molecular diagnostics for the week of July 10, 2023